188 related articles for article (PubMed ID: 26438425)
1. Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study.
Pollak TA; De Simoni S; Barimani B; Zelaya FO; Stone JM; Mehta MA
Psychopharmacology (Berl); 2015 Dec; 232(24):4515-24. PubMed ID: 26438425
[TBL] [Abstract][Full Text] [Related]
2. Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.
Bryant JE; Frölich M; Tran S; Reid MA; Lahti AC; Kraguljac NV
J Psychiatr Res; 2019 Oct; 117():108-115. PubMed ID: 31376621
[TBL] [Abstract][Full Text] [Related]
3. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia.
Holcomb HH; Lahti AC; Medoff DR; Cullen T; Tamminga CA
Neuropsychopharmacology; 2005 Dec; 30(12):2275-82. PubMed ID: 16034443
[TBL] [Abstract][Full Text] [Related]
4. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
5. Effects of ketamine on brain function during smooth pursuit eye movements.
Steffens M; Becker B; Neumann C; Kasparbauer AM; Meyhöfer I; Weber B; Mehta MA; Hurlemann R; Ettinger U
Hum Brain Mapp; 2016 Nov; 37(11):4047-4060. PubMed ID: 27342447
[TBL] [Abstract][Full Text] [Related]
6. [Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and neuroprotection following focal ischemia].
Werner C; Reeker W; Engelhard K; Lu H; Kochs E
Anaesthesist; 1997 Mar; 46 Suppl 1():S55-60. PubMed ID: 9163280
[TBL] [Abstract][Full Text] [Related]
7. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
[TBL] [Abstract][Full Text] [Related]
8. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network.
Lehmann M; Seifritz E; Henning A; Walter M; Böker H; Scheidegger M; Grimm S
Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1227-35. PubMed ID: 27075438
[TBL] [Abstract][Full Text] [Related]
10. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
11. Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.
Sahib AK; Loureiro JRA; Vasavada MM; Kubicki A; Joshi SH; Wang K; Woods RP; Congdon E; Wang DJJ; Boucher ML; Espinoza R; Narr KL
Eur Neuropsychopharmacol; 2020 Apr; 33():89-100. PubMed ID: 32061453
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of propofol on ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation.
Nakao S; Nagata A; Miyamoto E; Masuzawa M; Murayama T; Shingu K
Acta Anaesthesiol Scand; 2003 Mar; 47(3):284-90. PubMed ID: 12648194
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
14. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
Långsjö JW; Kaisti KK; Aalto S; Hinkka S; Aantaa R; Oikonen V; Sipilä H; Kurki T; Silvanto M; Scheinin H
Anesthesiology; 2003 Sep; 99(3):614-23. PubMed ID: 12960545
[TBL] [Abstract][Full Text] [Related]
15. Temporal dynamics of the pharmacological MRI response to subanaesthetic ketamine in healthy volunteers: A simultaneous EEG/fMRI study.
McMillan R; Forsyth A; Campbell D; Malpas G; Maxwell E; Dukart J; Hipp JF; Muthukumaraswamy S
J Psychopharmacol; 2019 Feb; 33(2):219-229. PubMed ID: 30663520
[TBL] [Abstract][Full Text] [Related]
16. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions.
Tamminga CA; Holcomb HH; Gao XM; Lahti AC
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():29-37. PubMed ID: 8866763
[TBL] [Abstract][Full Text] [Related]
17. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.
Rowland LM; Bustillo JR; Mullins PG; Jung RE; Lenroot R; Landgraf E; Barrow R; Yeo R; Lauriello J; Brooks WM
Am J Psychiatry; 2005 Feb; 162(2):394-6. PubMed ID: 15677610
[TBL] [Abstract][Full Text] [Related]
18. Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.
Burdett NG; Menon DK; Carpenter TA; Jones JG; Hall LD
Magn Reson Imaging; 1995; 13(4):549-53. PubMed ID: 7674850
[TBL] [Abstract][Full Text] [Related]
19. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
Shcherbinin S; Doyle O; Zelaya FO; de Simoni S; Mehta MA; Schwarz AJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4191-204. PubMed ID: 26223493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
